SCHEMBL4547708

SCHEMBL4547708

CC(C)(OC(=O)CCl)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.39
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ALDH1A1 P00352 2/20 0.36
JAK2 O60674 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 1/20 0.36
TSHR P16473 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CACNA1H O95180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL952118 0.89 EPHX2 (0.36) EPHX2CA12CA2CA7CA9
SCHEMBL25968927 0.86 EPHX2 (0.43) EPHX2CA12CA2CA7CA9
SCHEMBL12058487 0.84 EPHX2 (0.37) EPHX2CA12CA2CA7CA9
SCHEMBL97804 0.84 EPHX2 (0.37) EPHX2CA12CA2CA7CA9
SCHEMBL4547707 0.83 EPHX2 (0.36) EPHX2CA12CA2CA7CA9
SCHEMBL13527830 0.83 EPHX2 (0.36) EPHX2CA12CA2CA7CA9
SCHEMBL3290691 0.82 MEN1 (0.39) EPHX2ALDH1A1LMNAMEN1KMT2A
SCHEMBL12197283 0.81 EPHX2 (0.41) EPHX2CA12CA2CA7CA9
SCHEMBL2168089 0.81 EPHX2 (0.38) EPHX2CA12CA2CA7CA9
SCHEMBL5440799 0.80 EPHX2 (0.40) EPHX2CA12CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173351-B2 Compound and radiation-sensitive composition JSR CORPORATION (JP) 2012-05-08 US disclosed
US-8173351-B2 Compound and radiation-sensitive composition JSR CORPORATION (JP) 2012-05-08 US disclosed
US-20090274977-A1 COMPOUND AND RADIATION-SENSITIVE COMPOSITION JSR CORPORATION (JP) 2009-11-05 US disclosed
US-20090274977-A1 COMPOUND AND RADIATION-SENSITIVE COMPOSITION JSR CORPORATION (JP) 2009-11-05 US disclosed
EP-2100870-A1 COMPOUND AND RADIATION-SENSITIVE COMPOSITION JSR Corporation (JP) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090274977-A1 COMPOUND AND RADIATION-SENSITIVE COMPOSITION RAD51, SLC11A2, XRCC6 EPHX2 3619/4885CA12 2749/4885CA2 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.